Moin Andrew
Insider CIK 1996040 · SABS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SABS SAB Biotherapeutics, Inc. | M Exercise deriv | 2025-09-29 | 2025-10-01 | 17,400 | — | $0 | 211,100 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | M Exercise | 2025-09-29 | 2025-10-01 | 1,740,000 | $1.75 | $3.04M | 2,198,457 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2025-07-22 | 2025-07-24 | 228,500 | — | $0 | 228,500 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2025-07-22 | 2025-07-24 | 228,500 | — | $0 | 228,500 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2025-07-22 | 2025-07-24 | 114,250 | — | $0 | 114,250 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | M Exercise deriv | 2023-11-24 | 2023-11-28 | 31,269 | $1000.00 | $31.27M | 0 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | M Exercise deriv | 2023-11-24 | 2023-11-28 | 28,380 | $1000.00 | $28.38M | 28,380 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | M Exercise | 2023-11-24 | 2023-11-28 | 4,584,571 | — | $0 | 4,584,571 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2023-11-13 | 2023-11-14 | 13,269 | $1000.00 | $13.27M | 13,269 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | M Exercise deriv | 2023-11-13 | 2023-11-14 | 13,269 | — | $0 | 0 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2023-11-13 | 2023-11-15 | 13,269 | $1000.00 | $13.27M | 31,269 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2023-11-10 | 2023-11-14 | 13,269 | — | $0 | 13,269 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2023-11-10 | 2023-11-14 | 8,846 | — | $0 | 20,846 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2023-11-10 | 2023-11-14 | 22,115 | — | $0 | 52,115 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | M Exercise deriv | 2023-10-23 | 2023-10-24 | 16,269 | — | $0 | 0 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2023-10-23 | 2023-10-24 | 16,269 | $1000.00 | $16.27M | 18,000 | SEC↗ |